Related Experiment Video
Updated: Mar 6, 2026
Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
Prophylactic Measures During Induction for Acute Myeloid Leukemia
Matthew W McCarthy1, Thomas J Walsh2
1Division of General Internal Medicine, Weill Cornell Medical College, New York-Presbyterian Hospital, 525 East 68th Street, Box 331, New York, NY, 10065, USA. mwm9004@med.cornell.edu.
Purpose Of Review:
Improved management of infectious complications of acute myeloid leukemia (AML) has contributed substantially to the success of care over the past half century. An important approach to reducing infectious complications during the induction period of chemotherapy involves the use of prophylactic antibacterial, antiviral, and antifungal agents targeting likely pathogens.
Recent Findings:
There is not a one-size-fits-all approach to prophylaxis; every patient undergoing induction therapy should be evaluated individually and within the context of local microbiologic epidemiology and host risk factors. Pharmacologic and non-pharmacologic interventions as well as novel diagnostic platforms can help mitigate the risk of life-threatening infection in patients with AML who undergo induction chemotherapy.
Insights
Prophylaxis against infection in acute myeloid leukemia (AML) patients undergoing chemotherapy requires individualized plans. Tailoring antibacterial, antiviral, and antifungal strategies based on patient risk and local epidemiology is key for effective management.
Area of Science:
- Hematology
- Infectious Diseases
- Oncology
Background:
- Infectious complications significantly impact outcomes for patients with acute myeloid leukemia (AML).
- Advances in managing these infections have improved AML care over the last 50 years.
- Prophylaxis with antimicrobial agents is a cornerstone for reducing infections during induction chemotherapy.
Purpose of the Study:
- To review current strategies for preventing infectious complications in AML patients undergoing induction chemotherapy.
- To emphasize the importance of personalized prophylaxis regimens.
Main Methods:
- Review of existing literature on antimicrobial prophylaxis in AML.
- Analysis of factors influencing infection risk and management strategies.
- Discussion of pharmacologic, non-pharmacologic, and diagnostic approaches.
Main Results:
- A one-size-fits-all approach to prophylaxis is not effective for AML patients.
- Individual patient evaluation, considering local epidemiology and host factors, is crucial.
- Pharmacologic and non-pharmacologic interventions, alongside novel diagnostics, can reduce infection risk.
Conclusions:
- Personalized prophylaxis is essential for managing infectious complications in AML patients.
- Integrating local data and host risk assessment optimizes prophylactic strategies.
- Multifaceted interventions are vital for mitigating life-threatening infections in this vulnerable population.
More Related Videos
10:49Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
